H. Ludwig

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension

Sara Bringhen, Alberto Milan, Mattia D’Agostino et al. · Journal of Internal Medicine · 2019 · 60 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR

W-J Chng, Hartmut Goldschmidt, Meletios Α. Dimopoulos et al. · Leukemia · 2016 · 58 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma - a report on two cases

H. Kaufmann, J Ackermann, T. N x F sslinger et al. · Annals of Hematology · 2001 · 37 citations

Medicine, Hematology, Oncology +14

A paraneoplastic syndrome mimicking extrauterine pregnancy

P. Sagaster, Niklas Zojer, Gerhard Dekan et al. · Annals of Oncology · 2002 · 18 citations · Full text

Medicine, Gynecology, Obstetrics +12

Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer

P. Sagaster, J Flamm, Maria Flamm et al. · European Journal of Cancer · 1996 · 17 citations

Medicine, Oncology, Urology +11